Home > Industry/Domain > Pharmaceutical > Cancer drugs
Cancer drugs
Drugs, agents used in the treatment of cancer or conditions related to cancer.
Industry: Pharmaceutical
Add a new termContributors in Cancer drugs
Cancer drugs
yttrium Y 90 DOTA-biotin
Pharmaceutical; Cancer drugs
A radioconjugate of biotin and yttrium Y 90 (Y-90) linked through the bifunctional macrocyclic chelating agent tetra-azacyclododecanetetra-acetic acid (DOTA) with radioimmunotherapy property. Biotin ...
iodine I 124-labeled HSP90 inhibitor PUH71
Pharmaceutical; Cancer drugs
A radioconjugate containing the purine scaffold heat shock protein 90 (Hsp90) inhibitor PUH71 labeled with the radioisotope iodine I 124, with positron emitting activity. Hsp90 inhibitor PUH71 is ...
iodine I 124 FIAU
Pharmaceutical; Cancer drugs
A radioconjugate containing the nucleoside analog 2'-fluoro-2'-deoxy-1beta-D-arabinofuranosyl-5-iodouracil (FIAU) labeled with the radioisotope iodine I 124 with positron-emitting activity. ...
F 18 fluorodeoxygalactose
Pharmaceutical; Cancer drugs
A radioconjugate containing the galactose analogue 2-deoxy-2-fluoro-D-glucose (FDGal) that contains the positron-emitting radioactive isotope fluorine F18, used for imaging upon positron emitting ...
technetium Tc 99m hydroxydiphosphonate
Pharmaceutical; Cancer drugs
A radioconjugate containing hydroxydiphosphonate (HDP) labeled with the metastable radioisotope technetium Tc (99mTc), with radioimaging activity. Upon intravenous administration, skeletal uptake of ...
carbon C 14 eribulin acetate
Pharmaceutical; Cancer drugs
A radioconjugate containing the acetate salt of eribulin, labeled with the beta particle-emitting radioisotope carbon C 14 , with radioisotopic and potential antineoplastic activities. Upon ...
lutetium Lu 177-DOTA-octreotate
Pharmaceutical; Cancer drugs
A radioconjugate consisting of the somatostatin analog octreotate labeled with lutetium Lu 177 with receptor ligand, beta-emitting radioisotope, and potential antineoplastic activities. Lutetium Lu ...